Trial intelligence / Profile preview

Bioequivalence Study of Simvastatin 40 mg Film-coated Tablets in Healthy Thai Volunteers

TCTR20220119006Phase 1Not yet recruiting

Sponsor
International Bio Service
Start
May 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of simvastatin in hypercholesterolemia and hyperlipidemia (2 arms), sponsored by International Bio Service. Planned start May 2022; status: not yet recruiting.

02

Drugs

simvastatin
03

Conditions

hypercholesterolemiahyperlipidemia

Beyond the preview

Go deeper on TCTR20220119006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20220119006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call